BENDSZUS, M., S. BONEKAMP, E. BERGE, F. BOUTITIE, P. BROUWER, E. GIZEWSKI, A. KRAJINA, L. PIEROT, G. RANDALL, C. Z. SIMONSEN, K. ZELENAK, J. FIEHLER and G. THOMALLA. A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window. International Journal of Stroke. Hoboken: Wiley-Blackwell, 2019, vol. 14, No 1, p. 87-93. ISSN 1747-4930. Available from: https://dx.doi.org/10.1177/1747493018798558.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window
Authors BENDSZUS, M., S. BONEKAMP, E. BERGE, F. BOUTITIE, P. BROUWER, E. GIZEWSKI, A. KRAJINA, L. PIEROT, G. RANDALL, C. Z. SIMONSEN, K. ZELENAK, J. FIEHLER and G. THOMALLA.
Edition International Journal of Stroke, Hoboken, Wiley-Blackwell, 2019, 1747-4930.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.882
Doi http://dx.doi.org/10.1177/1747493018798558
UT WoS 000453594400014
Keywords (in Czech) Acute stroke therapy; intervention; ischemic stroke; protocols; radiology; stroke; therapy; treatment
Keywords in English Acute stroke therapy; intervention; ischemic stroke; protocols; radiology; stroke; therapy; treatment
Tags Excelence Science, FN HK, RIV, user
Changed by Changed by: Bc. Hana Vladíková, BBA, učo 244692. Changed: 7/12/2021 13:04.
Abstract
Rationale The benefit of thrombectomy in patients with intracranial large vessel occlusion of the anterior circulation has been shown in selected patients in previous randomized controlled trials, but patients with extended ischemic lesions were excluded in the majority of these trials. TENSION aims to demonstrate efficacy and safety of thrombectomy in patients with extended lesions in an extended time window (up to 12 h from onset or from last seen well). Design TENSION is an investigator-initiated, randomized controlled, open label, blinded endpoint, European, two-arm, postmarket study to compare the safety and effectiveness of thrombectomy as compared to best medical care alone in stroke patients with extended stroke lesions defined by an Alberta Stroke Program Early Computed Tomography Scan score of 3-5 and in an extended time window. In an adaptive design study, up to 665 patients will be randomized. Outcomes Primary efficacy endpoint will be clinical outcome defined by the modified Rankin Scale at 90-day poststroke. The main safety endpoint will be death and dependency (modified Rankin Scale 4-6) at 90 days. Additional effect measures include adverse events, health-related quality of life, poststroke depression, and costs utility assessment. Discussion TENSION may make effective treatment available for patients with severe stroke in an extended time window, thereby improving functional outcome and quality of life of thousands of stroke patients and reducing the individual, societal, and economic burden of death and disability resulting from severe stroke. TENSION is registered at ClinicalTrials.gov (ClinicalTrials.gov Identifier NCT03094715).
Links
90090, large research infrastructuresName: CZECRIN II
PrintDisplayed: 14/5/2024 03:29